Inclusion Criteria:  Demonstrate objective signs of Boderline/ Mild Ocular Surface Disease (OSD) [defined as mild symptoms, mild conjunctival staining (<2+ Superficial Punctate Keratitis), Tear Break-up Time <12s] or demonstrate symptoms of OSD determined by SPEED questionnaire (SPEED Score <10). Nucleus sclerosis up to 2+ planning to undergo FLACS + Premium PCIOL in both eyes. Ability to provide informed consent for procedures Ability to attend scheduled follow up visits No other corneal pathology to create unknown variability  Exclusion Criteria:  Age less than 18 Pregnancy/currently breast-feeding Inability to provide informed consent Documented adverse reaction to steroid (e.g. "steroid responder", allergy, etc) Punctal stenosis Previous corneal transplant surgery or refractive surgery Concurrent use of topical steroid eye drops Systemic, topical or intravitreal steroid use within 1 month of baseline Active history of chronic or recurrent inflammatory eye disease in either eye History of ocular herpetic infection (inclusive of Herpes Simplex 1/2, Varicella Zoster, Epstein Barr, Cytomegalovirus) History of neurotrophic keratitis, uncontrolled diabetes, or other disease entities that may preclude proper healing Diagnosis of Glaucoma or use of topical glaucoma drops Participation in other studies in the last 6 months